CKNWF Cell Kinetics Ltd featured news, full reports, and detailed charts
Cell Kinetics Ltd (CKNWF/CKNWF.OB) Wrap Up:
Cell Kinetics, Ltd. engages in the refining and commercialization of CellScan and related technology. It intends to commercially exploit the Cell Carrier, which is based on CellChip, a platform static cytometry technology that enables the simultaneous examination of various individual live cells using simple imaging methods, such as fluorescence microscopy. The company was founded in 1992 and is headquartered in Lod, Israel. Cell Kinetics, Ltd. is a subsidiary of Medis Technologies, Ltd.Cell Kinetics Ltd (CKNWF:OTC Bulletin Board Market)
Snapshot of Cell Kinetics Ltd (CKNWF)
|
OPEN
$0.0031
|
PREVIOUS CLOSE
$0.0031
|
|
|
DAY HIGH
$0.0032
|
DAY LOW
$0.0031
|
|
|
52 WEEK HIGH
11/25/08 - $1.20
|
52 WEEK LOW
10/28/09 - $0.0023
|
|
|
MARKET CAP
0.0
|
AVERAGE VOLUME 3 mo
2.1K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
0.0
|
|
|
CKNWF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CKNWF Top Compensated Officers
Executives, Board Directors
Key developments for Cell Kinetics Ltd (CKNWF)
Cell Kinetics Ltd. has to amend the company's Articles of Association to reflect the increase of share capital at the Annual General Meeting to be held on October 13, 2009.
Cell Kinetics Ltd., Annual General Meeting, Oct 13, 2009, at 08:00 GMT Time. Location: Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co., 40th Floor, Round Building, One Azrieli Center, Tel Aviv 67021, Israel. Agenda: To reelect Board of Directors until the company's next annual general meeting of shareholders; to approve the compensation to Directors; to approve one time payment of $1,500 to Chairman of the Board; to authorize as compensation quarterly payments of up to $4,500 each to the presiding Chairman; to approve the grant of options to purchase 25,000 Ordinary Shares, to be granted to the company's directors; to approve the grant of options to purchase 10,000 Ordinary Shares, to be granted to directors; to increase the share capital shall be ILS 5,000,000, divided into 500,000,000 Ordinary Shares, nominal value ILS 0.01 each, and to amend the Articles of Association to reflect such increase of share capital; to approve an extension of certain expiration dates for options held by all directors; to re-appoint Kost Forer Gabbay & Kasierer as the independent auditors for the year ending December 31, 2009; to receive audited financial statements for the year ended December 31, 2008.
Cell Kinetics Ltd. announced to reduce its operating expenses to avoid a situation in which it would be unable to meet its financial obligations to its employees and suppliers. As a result, the company has decided to dismiss all of its employees except for the company's administrative assistant. The dismissals will be effective at the end of August, except for the dismissal of the company's vice president (research and development) and chief operating officer, Asaf Halamish, which will be effective at the end of September.
CKNWF Competitors
| Company | Last | Change | |
| No competitor information is available for CKNWF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CKNWF | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 31.9x |
|
| Price/Book | 0.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 31.2x |
|
|
CKNWF |
||
